Summary
Signal counts
Assets tracked: 1
Watchlist assets: 1
Registry stop assets: 1
Sponsor overview
Ångstrom Pharmaceuticals
Public clinical-program risk signals across linked oncology Phase 2 assets for this sponsor.
Evidence links
Public sources
https://clinicaltrials.gov/study/NCT02046928
Assets
Linked programs
- A6: Registry Stop Signal (3/5)